Our pioneering journey to bring China-innovated pharmaceuticals to the world began in Shenzhen in 2001.
Fast forward to 2025, we are now a globalized modern biotech firm with integrated research, production and sales capacity.
Mar. 2001 | Shenzhen Chipscreen Biosciences, Ltd. established.
In Dec. 2009, Chipscreen Biosciences was awarded the "Special Contribution Award" by the Center for Drug Evaluation, CFDA
Jan. 2015 | Chipscreen Biosciences’ original new drug Chidamide received Chinese FDA approval with its press conference officially launched.